Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-21-000091
Filing Date
2021-08-12
Accepted
2021-08-12 16:08:22
Documents
83
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20210630.htm   iXBRL 10-Q 1885000
2 EX-10.3 exicureexhibit103-63021.htm EX-10.3 96077
3 EX-10.4 exicureexhibit104-63021.htm EX-10.4 75719
4 EX-31.1 exicureexhibit311-63021.htm EX-31.1 8048
5 EX-31.2 exicureexhibit312-63021.htm EX-31.2 7951
6 EX-32.1 exicureexhibit321-63021.htm EX-32.1 7593
12 xcur-20210630_g1.jpg GRAPHIC 184480
13 xcur-20210630_g2.jpg GRAPHIC 72571
  Complete submission text file 0001698530-21-000091.txt   8436765

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20210630.xsd EX-101.SCH 49190
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20210630_cal.xml EX-101.CAL 77730
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20210630_def.xml EX-101.DEF 222953
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20210630_lab.xml EX-101.LAB 653897
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20210630_pre.xml EX-101.PRE 417119
14 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20210630_htm.xml XML 1169188
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 211167571
SIC: 2834 Pharmaceutical Preparations